Abstract
Activating tyrosine kinase mutations or cytokine receptor signalling alterations have attracted attention as therapeutic targets for high-risk paediatric acute lymphoblastic leukaemia (ALL). We identified two novel kinase fusions, OFD1-JAK2 and NCOR1-LYN, in paediatric ALL patients with IKZF1 deletion, by mRNA sequencing. The patient with CSF2RA-CRLF2 also harboured IGH-EPOR. All these patients had high-risk features, such as high initial white blood cell counts and initial poor response to prednisolone. The functional analysis of these novel fusions is on-going to determine whether these genetic alterations can be targeted by drugs.
Keywords:
IKZF1; Ph-like ALL; kinase fusion; paediatric ALL.
© 2015 John Wiley & Sons Ltd.
MeSH terms
-
Child
-
Female
-
Gene Deletion*
-
Gene Fusion / genetics*
-
Humans
-
Ikaros Transcription Factor / genetics
-
Janus Kinase 2 / genetics
-
Male
-
Nuclear Receptor Co-Repressor 1 / genetics
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
-
Proteins / genetics
-
RNA, Messenger / genetics
-
Receptors, Cytokine / genetics
-
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / genetics
-
Sequence Analysis, RNA
-
src-Family Kinases / genetics
Substances
-
CRLF2 protein, human
-
CSF2RA protein, human
-
IKZF1 protein, human
-
NCOR1 protein, human
-
Nuclear Receptor Co-Repressor 1
-
OFD1 protein, human
-
Proteins
-
RNA, Messenger
-
Receptors, Cytokine
-
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
-
Ikaros Transcription Factor
-
Janus Kinase 2
-
lyn protein-tyrosine kinase
-
src-Family Kinases